News
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...
Anne Wojcicki lands 23andMe again. What $305 million deal means for company, customers, shareholders
Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...
FAFO parenting, gentle parenting, lighthouse parenting, attachment parenting—there’s no shortage of labels when it comes to ...
Anne Wojcicki’s nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...
A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe's co-founder ...
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne ...
14d
Stocktwits on MSN23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s BidMe Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and ...
In a letter sent today, Public Citizen urged California Attorney General Rob Bonta to launch an immediate investigation into ...
8d
Stocktwits on MSN23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA PrivacyA U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki ...
A U.S. district judge put on hold the bankruptcy sale of genetic testing company 23andMe late on Monday, giving California ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results